{
  "url": "https://openlegislation.uk/toys-and-cosmetic-products-restriction-of-chemical-substances-regulations-2022/schedule",
  "json_url": "https://openlegislation.uk/toys-and-cosmetic-products-restriction-of-chemical-substances-regulations-2022/schedule.json",
  "legislation": "uksi/2022/659",
  "legislation_title": "The Toys and Cosmetic Products (Restriction of Chemical Substances) Regulations 2022",
  "legislation_url": "https://openlegislation.uk/toys-and-cosmetic-products-restriction-of-chemical-substances-regulations-2022",
  "path": "schedule",
  "kind": "schedule",
  "number": null,
  "heading": "Amendments to Annex 2 (prohibited substances)",
  "text": "“\n1646\nCobalt\n7440-48-4\n231-158-0\n1647\nMetaldehyde (ISO); 2,4,6,8-tetramethyl- 1,3,5,7-tetraoxacyclooctane\n108-62-3\n203-600-2\n1648\nMethylmercuric chloride\n115-09-3\n204-064-2\n1649\nBenzo[rst]pentaphene\n189-55-9\n205-877-5\n1650\nDibenzo[b,def]chrysene; dibenzo[a,h]pyrene\n189-64-0\n205-878-0\n1651\nEthanol, 2,2’-iminobis-, N- (C13-15-branched and linear alkyl) derivs.\n97925-95-6\n308-208-6\n1652\nCyflumetofen (ISO); 2-methoxyethyl (RS)-2- (4-tert-butylphenyl)-2-cyano-3-oxo-3-(α,α,α-trifluoro-o-tolyl)propionate\n400882-07-7\n—\n1653\nDiisohexyl phthalate\n71850-09-4\n276-090-2\n1654\nhalosulfuron-methyl (ISO); methyl 3-chloro-5-{[(4,6- dimethoxypyrimidin-2-yl) carbamoyl]sulfamoyl}-1- methyl-1H-pyrazole-4- carboxylate\n100784-20-1\n—\n1655\n2-methylimidazole\n693-98-1\n211-765-7\n1656\nMetaflumizone (ISO);\n—\n—\n(EZ)-2’-[2-(4-cyanophenyl)-1-(α,α,α -trifluoro-m- tolyl)ethylidene]-[4-(trifluoromethoxy)phenyl] carbanilohydrazide [E-isomer ≥ 90 %, Z-isomer ≤ 10 % relative content]; [1]\n139968-49-3 [1]\n604-167-6 [1]\n(E)-2’-[2-(4-cyanophenyl)- 1-(α,α,α -trifluoro-m-tolyl) ethylidene]-[4-(trifluoromethoxy)phenyl]carbanilohydrazide [2]\n852403-68-0 [2]\n1657\nDibutylbis(pentane-2,4- dionato-O,O’)tin\n22673-19-4\n245-152-0’;\n1658\nSilicon carbide fibres (with diameter < 3 μm, length > 5 μm and aspect ratio ≥ 3:1)\n409-21-2\n308076-74-6\n206-991-8\n1659\nTris(2-methoxyethoxy) vinylsilane; 6-(2-methoxyethoxy)- 6-vinyl-2,5,7,10-tetraoxa-6-silaundecane\n1067-53-4\n213-934-0\n1660\nDioctyltin dilaurate; [1]\n3648-18-8 [1]\n222-883-3 [1]\nStannane, dioctyl-, bis (coco acyloxy) derivs. [2]\n91648- 39-4 [2]\n293-901-5 [2]\n1661\nDibenzo[def,p]chrysene; dibenzo[a,l]pyrene\n191-30-0\n205-886-4\n1662\nIpconazole (ISO);\n(1RS,2SR,5RS;1RS,2SR,5SR)-2-(4-chlorobenzyl)-5-isopropyl-1- (1H-1,2,4-triazol-1-ylmethyl) cyclopentanol\n125225-28-7\n—\n115850-69-6\n115937-89-8\n1663\nBis(2-(2-methoxyethoxy)ethyl)ether; tetraglyme\n143-24-8\n205-594-7\n1664\nPaclobutrazol (ISO); (2RS,3RS)-1-(4-chlorophenyl)-4,4-dimethyl- 2-(1H-1,2,4-triazol-1- yl)pentan-3-ol\n76738-62-0\n—\n1665\n2,2-bis(bromomethyl) propane-1,3-diol\n3296-90-0\n221-967-7\n1666\n2-(4-tert-butylbenzyl) propionaldehyde\n80-54-6\n201-289-8\n1667\nDiisooctyl phthalate\n27554-26-3\n248-523-5\n1668\n2-methoxyethyl acrylate\n3121-61-7\n221-499-3\n1669\nPyrithione zinc; (T-4)- bis[1-(hydroxy-.kappa.O)pyridine-2(1H)- thionato-.kappa.S]zinc\n13463-41-7\n236-671-3\n1670\nFlurochloridone (ISO); 3-chloro-4-(chloromethyl)-1-[3-(trifluoromethyl)phenyl]pyrrolidin-2-one\n61213-25-0\n262-661-3\n1671\n3-(difluoromethyl)-1- methyl-N-(3’,4’,5’-trifluorobiphenyl-2-yl) pyrazole-4-carboxamide; fluxapyroxad\n907204-31-3\n—\n1672\nN-(hydroxymethyl)acrylamide; methylolacrylamide; [NMA]\n924-42-5\n213-103-2\n1673\n5-fluoro-1,3-dimethyl-N-[2-(4- methylpentan-2-yl) phenyl]-1H-pyrazole- 4-carboxamide; 2’- [(RS)-1,3-dimethylbutyl]-5-fluoro-1,3-dimethylpyrazole-4-carboxanilide; penflufen\n494793-67-8\n—\n1674\nIprovalicarb (ISO); isopropyl [(2S)-3- methyl-1-{[1-(4- methylphenyl)ethyl] amino}-1-oxobutan-2- yl]carbamate\n140923-17-7\n—\n1675\nDichlorodioctylstannane\n3542-36-7\n222-583-2\n1676\nMesotrione (ISO); 2-[4-(methylsulfonyl)- 2-nitrobenzoyl]-1,3- cyclohexanedione\n104206-82-8\n—\n1677\nHymexazol (ISO); 3-hydroxy-5-methylisoxazole\n10004-44-1\n233-000-6\n1678\nImiprothrin (ISO); reaction mass of: [2,4- dioxo-(2-propyn-1-yl) imidazolidin-3-yl] methyl(1R)-cis-chrysanthemate; [2,4-dioxo-(2-propyn-1-yl) imidazolidin-3-yl] methyl(1R)-trans-chrysanthemate\n72963-72-5\n428-790-6\n1679\nBis(α,α-dimethylbenzyl) peroxide\n80-43-3\n201-279-3\n”",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2022/659/schedule",
    "retrieved_at": "2026-10-28T21:58:54.315881+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}